Induction Chemotherapy and Chemoradiotherapy in Nasopharyngeal Cancers (GORTEC-NPC2006)

This study is currently recruiting participants.

Verified June 2011 by Groupe Oncologie Radiotherapie Tete et Cou

Sponsor:

Information provided by:

Groupe Oncologie Radiotherapie Tete et Cou

ClinicalTrials.gov Identifier:

NCT00828386

First received: January 22, 2009

Last updated: June 23, 2011

Last verified: June 2011

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	September 2016
Estimated Primary Completion Date:	May 2013 (Final data collection date for primary outcome measure)

No publications provided by Groupe Oncologie Radiotherapie Tete et Cou

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Bourhis J, Sire C, Graff P, Grégoire V, Maingon P, Calais G, Gery B, Martin L, Alfonsi M, Desprez P, Pignon T, Bardet E, Rives M, Geoffrois L, Daly-Schveitzer N, Sen S, Tuchais C, Dupuis O, Guerif S, Lapeyre M, Favrel V, Hamoir M, Lusinchi A, Temam S, Pinna A, Tao YG, Blanchard P, Aupérin A. Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial. Lancet Oncol. 2012 Feb;13(2):145-53. Epub 2012 Jan 18.

To Top